Jay Backstrom
Vermögen: 4 Mio $ am 30.06.2026
Vermögen: 4 Mio $ am 30.06.2026
Zurzeit bekleidet Jay T. Backstrom die Position des Executive VP & Head-Research & Development bei Acceleron Pharma, Inc. Er ist außerdem Mitglied des Vorstands von Autolus Therapeutics Plc. In seiner bisherigen Laufbahn hatte er die Position des medizinischen Direktors des Samuel U. Rodgers Community Health Center, Inc. inne, war Chief Medical Officer bei Celgene Corp., Executive Director-Medical & Scientific Services bei Quintiles, Inc. (Kalifornien) und Vice President-Global Medical & Safety bei Pharmion Corp. Er promovierte an der Temple University School of Medicine und erwarb einen Abschluss an der St Louis University School of Public Health.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 26.03.2025 | 76 277 ( 0,07 % ) | 4 Mio $ | 30.06.2026 | |
| 08.07.2026 | 1 447 ( 0 % ) | 53 698 $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 08.07.2025 |
Be Biopharma, Inc.
Be Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and produces engineered B cell medicines | Direktor/Vorstandsmitglied | 16.12.2021 |
Disc Medicine Opco, Inc.
Disc Medicine Opco, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapies for hematologic diseases | Direktor/Vorstandsmitglied | 01.12.2021 |
Pancreatic Cancer Action Network, Inc.
Pancreatic Cancer Action Network, Inc. Medical/Nursing ServicesHealth Services Operates a charity which focuses on the early diagnosis of pancreatic cancer | Direktor/Vorstandsmitglied | 01.07.2023 |
| Unternehmen | Position | Ende |
|---|---|---|
| LAVA THERAPEUTICS | Direktor/Vorstandsmitglied | 07.11.2025 |
| SCHOLAR ROCK HOLDING CORPORATION | Vorstandsvorsitzender | 27.04.2025 |
| DISC MEDICINE, INC. | Direktor/Vorstandsmitglied | 09.06.2023 |
| AUTOLUS THERAPEUTICS PLC | Direktor/Vorstandsmitglied | 28.02.2023 |
| ACCELERON PHARMA INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2021 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 16 |
|---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Pharmion Corp.
Pharmion Corp. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of products for the treatment of hematology & oncology patients | Health Technology |
Quintiles, Inc. (California)
Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Provides therapeutic services | Health Services |
Acceleron Pharma, Inc.
Acceleron Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company which develops protein therapeutics for cancer and orphan diseases | Health Technology |
Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
Samuel U. Rodgers Community Health Center, Inc.
Samuel U. Rodgers Community Health Center, Inc. Samuel U. Rodgers Community Health Center, Inc. is a federally qualified nonprofit health organization dedicated to providing affordable healthcare to over 23,000 individuals annually. The private company is based in Kansas City, MO. Established in 1968, the center offers comprehensive services for all ages, including medical care, behavioral health counseling, dental and vision care, telehealth, and health insurance assistance. It provides integrated physical and mental health support, specialized programs for men’s health and maternal and infant health, and services accessible regardless of insurance status. The center is expanding its facilities to address primary care shortages and improve access for vulnerable children, and offers patient education resources, interpretation services in over 40 languages, and community partnerships to enhance care accessibility. | |
Pancreatic Cancer Action Network, Inc.
Pancreatic Cancer Action Network, Inc. Medical/Nursing ServicesHealth Services Operates a charity which focuses on the early diagnosis of pancreatic cancer | Health Services |
St Louis University School of Public Health
St Louis University School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Scholar Rock Holding Corp.
Scholar Rock Holding Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focused on the discovery, development and delivery medicines for neuromuscular, cardiometabolic disorders, cancer, fibrosis and iron-restricted anemia | Health Technology |
Autolus Therapeutics Plc
Autolus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of gene therapies | Health Technology |
LAVA Therapeutics NV
LAVA Therapeutics NV Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops antibodies for the treatment of cancer | Health Technology |
Disc Medicine Opco, Inc.
Disc Medicine Opco, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapies for hematologic diseases | Commercial Services |
Lewis Katz School of Medicine
Lewis Katz School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Be Biopharma, Inc.
Be Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and produces engineered B cell medicines | Health Technology |
Gemini Therapeutics, Inc.
Gemini Therapeutics, Inc. BiotechnologyHealth Technology Develops drugs for dry age-related macular degeneration and associated rare genetic diseases | Health Technology |
Disc Medicine, Inc.
Disc Medicine, Inc. BiotechnologyHealth Technology Develops therapies addressing red blood cell production in hematologic diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen